N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-04-14
DOI
10.3389/fphar.2014.00070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- N-acetyl-seryl-aspartyl-lysyl-proline Inhibits Diabetes-Associated Kidney Fibrosis and Endothelial-Mesenchymal Transition
- (2014) Takako Nagai et al. Biomed Research International
- Renal Antifibrotic Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline in Diabetic Rats
- (2013) G. Castoldi et al. AMERICAN JOURNAL OF NEPHROLOGY
- Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
- (2013) Jianhua He et al. Clinical and Experimental Nephrology
- N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats
- (2013) Germán E. González et al. CLINICAL SCIENCE
- Sodium restriction on top of renin–angiotensin–aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients
- (2013) Arjan J. Kwakernaak et al. JOURNAL OF HYPERTENSION
- Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis
- (2013) Yiqin Zuo et al. KIDNEY INTERNATIONAL
- Origin and function of myofibroblasts in kidney fibrosis
- (2013) Valerie S LeBleu et al. NATURE MEDICINE
- MicroRNAs in Kidney Fibrosis and Diabetic Nephropathy: Roles on EMT and EndMT
- (2013) Swayam Prakash Srivastava et al. Biomed Research International
- Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
- (2013) Keizo Kanasaki et al. Frontiers in Endocrinology
- Treatment with N-acetyl-seryl-aspartyl-lysyl-proline prevents experimental autoimmune myocarditis in rats
- (2012) Pablo Nakagawa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pathophysiology of the aging kidney and therapeutic interventions
- (2012) Keizo Kanasaki et al. HYPERTENSION RESEARCH
- Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
- (2012) Hui Yao Lan International Journal of Biological Sciences
- MicroRNA-324-3p Promotes Renal Fibrosis and Is a Target of ACE Inhibition
- (2012) D. Macconi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A New Antifibrotic Target of Ac-SDKP: Inhibition of Myofibroblast Differentiation in Rat Lung with Silicosis
- (2012) Hong Xu et al. PLoS One
- FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression
- (2012) Pei-Yu Chen et al. Cell Reports
- The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy
- (2011) Claire E. Hills et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Fibroblasts and myofibroblasts in renal fibrosis
- (2011) Soma Meran et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Sodium Intake, ACE Inhibition, and Progression to ESRD
- (2011) S. Vegter et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
- (2011) Jeffrey L. Barnes et al. KIDNEY INTERNATIONAL
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Angiotensin-Converting Enzyme N-Terminal Inactivation Alleviates Bleomycin-Induced Lung Injury
- (2010) Ping Li et al. AMERICAN JOURNAL OF PATHOLOGY
- Ac-SDKP inhibits transforming growth factor-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts
- (2010) Hongmei Peng et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin β4 in neoplastic diseases
- (2010) Jian-Miao Liu et al. Annals of the New York Academy of Sciences
- Thymosin β4 and its posttranslational modifications
- (2010) E. Hannappel Annals of the New York Academy of Sciences
- Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster
- (2010) Mohd Akif et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)
- (2010) Kenneth E Bernstein et al. CURRENT OPINION IN PHARMACOLOGY
- The regulation of cell growth and survival by aldosterone
- (2010) Ruth Dooley Frontiers in Bioscience-Landmark
- The N Domain of Human Angiotensin-I-converting Enzyme
- (2010) Colin S. Anthony et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preservation of basal AcSDKP attenuates carbon tetrachloride-induced fibrosis in the rat liver
- (2010) Yuan-Wen Chen et al. JOURNAL OF HEPATOLOGY
- Resolved: EMT Produces Fibroblasts in the Kidney
- (2010) M. Zeisberg et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
- (2010) Faramarz Ismail-Beigi et al. LANCET
- Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies
- (2010) Jian-Miao Liu et al. LEUKEMIA & LYMPHOMA
- The Role of Tubulointerstitial Inflammation in the Progression of Chronic Renal Failure
- (2010) Bernardo Rodríguez-Iturbe et al. NEPHRON CLINICAL PRACTICE
- The pathogenesis of idiopathic pulmonary fibrosis
- (2010) William R. Coward et al. Therapeutic Advances in Respiratory Disease
- Investigating the Domain Specificity of Phosphinic Inhibitors RXPA380 and RXP407 in Angiotensin-Converting Enzyme
- (2009) Wendy L. Kröger et al. BIOCHEMISTRY
- Renoprotective properties of pirfenidone in subtotally nephrectomized rats
- (2009) Koji Takakuta et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pirfenidone Is Renoprotective in Diabetic Kidney Disease
- (2009) S. P. RamachandraRao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast activation and myofibroblast generation in obstructive nephropathy
- (2009) María T. Grande et al. Nature Reviews Nephrology
- Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension
- (2008) Chun-Xia Lin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
- (2008) Umesh Sharma et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
- (2008) Yun-He Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms
- (2008) Roben G. Gieling et al. Clinics in Liver Disease
- Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
- (2007) Sebastien Fuchs et al. HYPERTENSION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now